ELECTRONIC CAPTURE OF CANCER CLAIMS DATA FOR THE SEER PROGRAM

SEER 计划的癌症索赔数据的电子采集

• 批准号: 10923772
• 负责人: BRIAN GOCKERMAN
• 金额: $ 30.6万
• 依托单位国家: 美国
• 财政年份: 2021
• 资助国家: 美国
• 起止时间: 2021-09-07 至 2024-09-06
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10923772
• 关键词: Area; Cancer Patient; Cause of Death; Consent; Data; Dose; Electronics; Guidelines; Health Personnel; Hospitals; Individual; Laws; Life; Malignant Neoplasms; Medical; National Cancer Institute; Oncologist; Oncology; Patients; Physicians' Offices; Provider; Recurrence; Reporting; SEER Program; Series; Source; System; Systemic Therapy; cancer care; data registry; demographics; follow-up; interest; neoplasm registry; surveillance data; transmission process

Healthcare providers in all 50 states are required by law to report new cases of cancer to their state’s cancer registries. The National Cancer Institute’s (NCI’s) Surveillance, Epidemiology, and End Results (SEER) Program, collects data on each and every cancer patient in SEER covered areas. This data includes demographics, a description of their cancer, limited initial treatment information, and patient follow-up including cause of death for deceased patients. In the past the main source of registry data came from Hospitals. With the increasing complexity of cancer care and delivery systems, patients are being increasingly treated exclusively at physicians’ offices. Thus, for SEER to continue capturing all cancer cases and their treatment information SEER is interested in obtaining other sources of data such as claims data from oncology practices. Oncology practice claims has proven to be a rich source of information on detailed systemic therapy, including agents, doses administration dates etc.

法律要求所有 50 个州的医疗保健提供者向其州的癌症登记处报告新的癌症病例。国家癌症研究所 (NCI) 的监测、流行病学和最终结果 (SEER) 计划收集每个病例的数据。 这些数据包括人口统计数据、癌症描述、有限的初始治疗信息以及患者随访（包括已故患者的死亡原因）。过去，登记数据的主要来源来自医院。随着癌症护理和治疗系统的日益复杂，患者越来越多地在医生办公室接受治疗，因此 SEER 能够继续捕获所有癌症病例。 及其治疗信息 SEER 有兴趣获取其他数据来源，例如来自肿瘤学实践的索赔数据，已被证明是详细系统治疗的丰富信息来源，包括。 药物、剂量、给药日期等。